FDA recognizes the potential of Truvada as a preventative HIV drug


The FDA acknowledged Tuesday that the drug, Truvada, appears to be a safe and effective means of reducing HIV infections in high-risk individuals. An outside panel of experts will review the FDA's analysis of Truvada on Thursday. This group will decide if the drug should be prescribed in the US to HIV negative individuals. Despite Truvada's potential, the concern is that the drug will be used in place of condoms instead of in combination with prophylactics.